<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000765003"><TermName>VIP regimen</TermName><TermPronunciation>(… REH-jih-men)</TermPronunciation><TermDefinition><DefinitionText>An abbreviation for a chemotherapy combination used to treat advanced testicular cancer. It is often used in patients who cannot receive bleomycin. It includes the drugs etoposide (VePesid), ifosfamide, and cisplatin (Platinol). Also called VIP.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000766701" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;VIP regimen&quot;" language="en" id="_3"/><MediaLink ref="CDR0000766702" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;régimen VIP&quot;" language="es" id="_4"/><SpanishTermName>régimen VIP</SpanishTermName><SpanishTermDefinition><DefinitionText>Abreviatura de un régimen de quimioterapia combinada que se usa para tratar el cáncer de testículo en estadio avanzado. Con frecuencia, se usa para pacientes que no pueden recivir bleomicina. Incluye los medicamentos etopósido, (VePesid), ifosfamida y cisplatino (Platinol). También se llama VIP.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2014-10-02</DateFirstPublished><RelatedInformation><RelatedDrugSummaryRef href="CDR0000764894">VIP</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
